DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Optimark (Gadoversetamide) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (20)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Optimark (Gadoversetamide) disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Optimark side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02

Patient: 54 year old male

Reactions: Pruritus, Muscle Contractions Involuntary, Pain, Abasia, Neuropathic Ulcer, Erythema, Muscle Rigidity, Neuropathy Peripheral, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Muscle Spasms, Excoriation, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Emotional Distress, Arthralgia, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2000-11-29

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2000-12-12
    End date: 2000-12-12

Optimark

Magnevist

Omniscan

Other drugs received by patient: Epoetin Alfa; Phoslo; Lorazepam; Misoprostol; Cefazolin Sodium; Vitamin E; Vitamin D; Amiodarone Hydrochloride; Lansoprazole; Humulin R; Calcium Acetate; Verapamil HCL; Atacand HCT; Minoxidil; Cytotec



Possible Optimark side effects in female

Reported by a physician from United States on 2012-06-18

Patient: female

Reactions: Abdominal Pain, Pulmonary Hypertension, Pruritus, Contusion, Nocturia, Hyperhidrosis, Cardiomegaly, Pericardial Effusion, Off Label Use, Biliary Dilatation, Melanocytic Naevus, Open Wound, Nephrogenic Systemic Fibrosis, Joint Swelling, Impaired Gastric Emptying, Mobility Decreased, Renal Transplant, Wheezing, Chills, Morganella Infection, Polyuria, Constipation, Splenic Infarction, Gastritis, Myalgia, Weight Increased, Fatigue, Hepatomegaly, Skin Ulcer, Dizziness, Pleural Effusion, Musculoskeletal Stiffness, Cholecystitis, Splenomegaly, Decreased Appetite, Device Related Sepsis, Nausea, Muscular Weakness, Rash, Hypercoagulation, Cerebrovascular Accident, Ascites, Arthralgia, Bradycardia, Renal Tubular Necrosis, Proteus Infection

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Optimark
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-08-02
    End date: 2006-08-02

Optimark
    Dosage: 20 ml, single
    Indication: Angiogram
    Start date: 2006-08-05
    End date: 2006-08-05

Other drugs received by patient: Metoclopramide; Procardia XL; Epogen; Lisinopril; Renagel; Colace; Micardis; Terazosin HCL; Calcium Acetate; Novolog; Levaquin; Metoprolol Succinate Extended Release; Flagyl



Possible Optimark side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14

Patient: 54 year old male

Reactions: Abasia, Pain, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Emotional Distress, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2000-12-12
    End date: 2000-12-12

Optimark

Omniscan



Possible Optimark side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-11

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Nephrogenic Systemic Fibrosis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Prohance
    Indication: Renal Mass
    Start date: 2003-07-03
    End date: 2003-07-03

Omniscan
    Indication: Liver Disorder
    Start date: 2004-07-13
    End date: 2004-07-13

Omniscan
    Indication: Neck Pain
    Start date: 2004-07-13
    End date: 2004-07-13

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2004-07-13
    End date: 2004-07-13

Prohance
    Indication: Renal Scan
    Start date: 2003-07-03
    End date: 2003-07-03

Omniscan
    Indication: Osteomyelitis
    Start date: 2004-07-13
    End date: 2004-07-13

Contrast Media
    Indication: Decubitus Ulcer
    Start date: 2005-04-14
    End date: 2005-04-14

Magnevist

Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-04-14
    End date: 2005-04-14

Contrast Media
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-04-14
    End date: 2005-04-14

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-07-13
    End date: 2004-07-13

Multihance
    Indication: Diagnostic Procedure

Optimark

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-10-15
    End date: 2004-10-15

Other drugs received by patient: Plavix; Iron; Clonidine; Calcitriol; Proamatine; Epogen; Renvela; Cozaar; Calcium Carbonate; Metoprolol Tartrate; Sensipar; Rena-Vite; Phoslo; Hectorol; Renagel; Amlodipine; Fosrenol; Lisinopril; Foltx



Possible Optimark side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Pruritus, Hyperkeratosis, Pain, Skin Burning Sensation, Skin Hyperpigmentation, Erythema, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Skin Lesion, Fibrosis, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, DRY Skin, Hypoaesthesia, Skin Induration, Deformity, Skin Tightness, Paraesthesia, Skin Plaque, Rash Macular, Gait Disturbance, Scar, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2005-04-14
    End date: 2005-04-14

Omniscan
    Dosage: 15 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-10-15
    End date: 2004-10-15

Prohance
    Dosage: 17 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2003-07-03
    End date: 2003-07-03

Magnevist

Omniscan
    Dosage: 30 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-07-13
    End date: 2004-07-13

Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-04-14
    End date: 2005-04-14

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Optimark

Multihance

Other drugs received by patient: Calcitriol; Plavix; Fosrenol; Sensipar; Clonidine; Renvela; Rena-Vite; Calcium Carbonate; Metoprolol Tartrate; Renagel; Cozaar; Phoslo; Epogen; Hectorol; Iron; Amlodipine; Lisinopril; Proamatine; Foltx



Possible Optimark side effects in female

Reported by a physician from United States on 2012-05-04

Patient: female

Reactions: Pulmonary Hypertension, Abdominal Pain, Renal Transplant, Chills, Hyperhidrosis, Cardiomegaly, Splenic Infarction, Pericardial Effusion, Gastritis, Weight Increased, Off Label Use, Hepatomegaly, Biliary Dilatation, Pleural Effusion, Musculoskeletal Stiffness, Cholecystitis, Splenomegaly, Decreased Appetite, Device Related Sepsis, Nausea, Nephrogenic Systemic Fibrosis, Hypercoagulation, Cerebrovascular Accident, Ascites, Renal Tubular Necrosis, Bradycardia, Impaired Gastric Emptying, Proteus Infection

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Optimark
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-08-02
    End date: 2006-08-02

Optimark
    Dosage: 20 ml, single
    Indication: Angiogram
    Start date: 2006-08-05
    End date: 2006-08-05

Other drugs received by patient: Lisinopril; Novolog; Metoclopramide; Procardia XL; Flagyl; Levaquin; Colace; Metoprolol Succinate Extended Release; Terazosin HCL; Micardis; Renagel; Calcium Acetate; Epogen



Possible Optimark side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-02

Patient: male, weighing 77.6 kg (170.6 pounds)

Reactions: Femoral Arterial Stenosis, Headache, Cyst, Pulmonary Granuloma, Tunnel Vision, Malaise, Nodule, Temperature Intolerance, Back Pain, Actinic Keratosis, Prostate Cancer, Coronary Artery Disease, Nephrogenic Systemic Fibrosis, Helicobacter Infection, Neurodermatitis, Hypoaesthesia, Stress, Activities of Daily Living Impaired, Ventricular Tachycardia, Ear Pain, Fall, Poor Quality Sleep, Fatigue, Basal Cell Carcinoma, Dizziness, Acute Myocardial Infarction, Vomiting, Supraventricular Extrasystoles, Nausea, Squamous Cell Carcinoma, Bundle Branch Block Left, Rash, Ascites, Carotid Artery Stenosis, Meniscus Lesion, Diarrhoea, Atrioventricular Block, Gait Disturbance, Arthritis, Asthenia, Infection

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Optimark
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-12-15
    End date: 2005-12-15

Omniscan
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-09-23

Other drugs received by patient: Simvastatin; Diovan; Renal Softgel; Minoxidil



Possible Optimark side effects in female

Reported by a physician from United States on 2012-05-01

Patient: female

Reactions: Abdominal Pain, Orthostatic Hypotension, Pulmonary Embolism, Osteomyelitis, Headache, Ingrowing Nail, Staphylococcal Bacteraemia, Arteriosclerosis, Back Pain, Localised Infection, Pneumonia, Anaemia, Hypotension, Helicobacter Infection, Nephrogenic Systemic Fibrosis, Nail Hypertrophy, Osteopenia, Osteosclerosis, Iliac Artery Stenosis, Dehydration, Impaired Gastric Emptying, Spinal Column Stenosis, Pain, Fall, Hypoacusis, Skin Ulcer, Intervertebral Discitis, Chest Pain, Arteriovenous Fistula Thrombosis, Blood Pressure Increased, Vomiting, Nausea, Syncope, Diarrhoea, Sepsis, Retroperitoneal Lymphadenopathy, Spinal Osteoarthritis, Deep Vein Thrombosis, Infectious Peritonitis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Optimark
    Dosage: unk, single
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-03-03
    End date: 2006-03-03

Multihance
    Dosage: 15 ml, single
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2008-07-30
    End date: 2008-07-30

Gadolinium
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2010-01-01
    End date: 2010-01-01

Optimark
    Indication: Angiogram

Omniscan
    Dosage: 40 ml, single
    Indication: Angiogram
    Start date: 2007-02-06
    End date: 2007-02-06

Multihance
    Dosage: 17 ml, single
    Start date: 2009-11-19
    End date: 2009-11-19



Possible Optimark side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-30

Patient: 43 year old male, weighing 118.0 kg (259.6 pounds)

Reactions: Pain in Extremity, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Deformity, Skin Tightness, Emotional Distress, Anxiety, Skin Discolouration, Fibrosis, Depression, Mobility Decreased, Scar

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-04-25
    End date: 2006-04-25

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: 20 ml, once
    Start date: 2006-05-21
    End date: 2006-05-21

Other drugs received by patient: Nephrocaps; Losartan Potassium; Aldactone; Insulin; Albumin (Human); Cardizem; Zemplar; Procardia XL; Aranesp; Catapres; Procrit; Phoslo



Possible Optimark side effects in male

Reported by a lawyer from United States on 2012-04-19

Patient: male

Reactions: Femoral Arterial Stenosis, Headache, Cyst, Pulmonary Granuloma, Tunnel Vision, Malaise, Nodule, Actinic Keratosis, Back Pain, Prostate Cancer, Coronary Artery Disease, Nephrogenic Systemic Fibrosis, Hypoaesthesia, Helicobacter Infection, Neurodermatitis, Stress, Activities of Daily Living Impaired, Ventricular Tachycardia, Ear Pain, Fall, Poor Quality Sleep, Fatigue, Basal Cell Carcinoma, Dizziness, Acute Myocardial Infarction, Squamous Cell Carcinoma, Nausea, Supraventricular Extrasystoles, Bundle Branch Block Left, Rash, Ascites, Carotid Artery Stenosis, Meniscus Lesion, Diarrhoea, Atrioventricular Block, Gait Disturbance, Asthenia, Arthritis, Infection

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Optimark
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-12-15
    End date: 2005-12-15

Omniscan
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-09-23

Other drugs received by patient: Minoxidil; Simvastatin; Diovan; Renal Softgel



Possible Optimark side effects in male

Reported by a lawyer from United States on 2012-04-02

Patient: male

Reactions: Femoral Arterial Stenosis, Headache, Cyst, Pulmonary Granuloma, Tunnel Vision, Malaise, Nodule, Actinic Keratosis, Back Pain, Prostate Cancer, Coronary Artery Disease, Hypoaesthesia, Nephrogenic Systemic Fibrosis, Helicobacter Infection, Neurodermatitis, Stress, Activities of Daily Living Impaired, Ventricular Tachycardia, Ear Pain, Fall, Poor Quality Sleep, Fatigue, Basal Cell Carcinoma, Dizziness, Acute Myocardial Infarction, Nausea, Squamous Cell Carcinoma, Supraventricular Extrasystoles, Bundle Branch Block Left, Rash, Ascites, Meniscus Lesion, Carotid Artery Stenosis, Diarrhoea, Atrioventricular Block, Gait Disturbance, Arthritis, Asthenia, Infection

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Omniscan
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-09-23

Optimark
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-12-15
    End date: 2005-12-15

Other drugs received by patient: Renal Softgel; Diovan; Simvastatin; Minoxidil



Possible Optimark side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-05

Patient: female, weighing 78.7 kg (173.1 pounds)

Reactions: Pain, Abasia, Skin Induration, Nephrogenic Systemic Fibrosis, Deformity, Skin Tightness, Emotional Distress, Anxiety, Skin Discolouration, Fibrosis, Coordination Abnormal, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist
    Indication: Imaging Procedure

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-02-25
    End date: 2008-02-25

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2004-06-04
    End date: 2004-06-04

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-08-24
    End date: 2002-08-24

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2004-07-16
    End date: 2004-07-16

Optimark
    Indication: Imaging Procedure

Multihance
    Indication: Imaging Procedure

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2005-05-25
    End date: 2005-05-25

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-06-04
    End date: 2008-06-04

Omniscan
    Indication: Imaging Procedure

Prohance
    Indication: Imaging Procedure

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2004-05-17
    End date: 2004-05-17

Other drugs received by patient: Venofer; Aranesp; Clonidine; Metoprolol Succinate; Altace; Coumadin; Atenolol; Renagel; Enalapril Maleate; Epogen; Norvasc; Renvela



Possible Optimark side effects in male

Reported by a physician from United States on 2011-12-02

Patient: male

Reactions: Transplant Failure, Cyst, Catheter Placement, Basal Cell Carcinoma, Skin Cancer, Nodule, Salivary Gland Operation, Actinic Keratosis, Squamous Cell Carcinoma, Prostate Cancer, Nephrogenic Systemic Fibrosis, Neurodermatitis, Stress, Meniscus Lesion, Cardiac Pacemaker Insertion, Activities of Daily Living Impaired, Gait Disturbance, Asthenia, Arthritis, Infection

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Omniscan
    Dosage: unk
    Start date: 2004-09-23

Optimark
    Dosage: unk
    Start date: 2005-12-15
    End date: 2005-12-15

Optimark
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2001-11-01

Omniscan
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1998-06-01

Other drugs received by patient: Diovan; Minoxidil; Renal Softgel; Simvastatin



Possible Optimark side effects in 42 year old male

Reported by a consumer/non-health professional from United States on 2011-11-28

Patient: 42 year old male

Reactions: Joint Contracture, Pain, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Emotional Distress, Anxiety, Musculoskeletal Stiffness, Gait Disturbance, Fibrosis, Asthenia, Extremity Contracture, Scar, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Vicodin; Pancrelipase; Novolog; Antineoplastic Agents; Fexofenadine; Diclofenac Sodium ER; Lantus; Omega-3 Fatty Acids; Labetalol HCL; Ranitidine; Glipizide; Glucagon; Cartia XT; Mycophenolate Mofetil (Cellcept); Prograf; Prednisone TAB; Therems; Paracetamol W / Tramadol Hydrochloride



Possible Optimark side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-15

Patient: 42 year old male, weighing 81.0 kg (178.2 pounds)

Reactions: Skin Exfoliation, Joint Contracture, Pain, Post Inflammatory Pigmentation Change, Neuropathic Arthropathy, Stasis Dermatitis, Anhedonia, Joint Range of Motion Decreased, Skin Ulcer, Oedema, Rash Generalised, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, DRY Skin, Skin Induration, Skin Tightness, Rash Macular, Anxiety, Emotional Distress, Xerosis

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Magnevist
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1999-08-18
    End date: 1999-08-18

Magnevist

Omniscan

Omniscan
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2005-12-06
    End date: 2005-12-06

Optimark
    Dosage: 30 ml, once
    Start date: 2006-03-23
    End date: 2006-03-23

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-09-01
    End date: 2005-09-01

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Brain

Omniscan
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-05-16
    End date: 2006-05-16

Other drugs received by patient: Levothroid; Lotrel; Epogen; Lanoxin; Phoslo; Imuran; Ascorbic Acid W / Folic Acid / Iron / Vitamin B12; Protonix; Acyclovir; Morphine; Reglan; Pravachol; Neurontin; Quinine Sulfate; Imodium; Gastromark; Avinza; Niferex; Coumadin; Lantus; Novolog; Rena-Vite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Aciphex; Nephrocaps; Cyclosporine



Possible Optimark side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-10

Patient: female, weighing 78.7 kg (173.1 pounds)

Reactions: Pain, Abasia, Nephrogenic Systemic Fibrosis, Skin Induration, Deformity, Skin Tightness, Emotional Distress, Anxiety, Skin Discolouration, Coordination Abnormal, Fibrosis, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2005-05-25
    End date: 2005-05-25

Optimark
    Indication: Imaging Procedure

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-08-24
    End date: 2002-08-24

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-02-25
    End date: 2008-02-25

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2004-07-16
    End date: 2004-07-16

Multihance
    Indication: Imaging Procedure

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-06-04
    End date: 2008-06-04

Magnevist
    Indication: Imaging Procedure

Prohance
    Indication: Imaging Procedure

Omniscan
    Indication: Imaging Procedure

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2004-05-17
    End date: 2004-05-17

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2004-06-04
    End date: 2004-06-04

Other drugs received by patient: Metoprolol; Renagel; Coumadin; Enalapril Maleate; Clonidine; Altace; Atenolol; Renvela; Epogen; Aranesp; Norvasc; Venofer



Possible Optimark side effects in 73 year old male

Reported by a consumer/non-health professional from United States on 2011-11-08

Patient: 73 year old male

Reactions: Pain, Joint Contracture, Skin Induration, Nephrogenic Systemic Fibrosis, Skin Tightness, Anxiety, Emotional Distress, Anhedonia, Joint Range of Motion Decreased, Injury, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Dosage: 20cc
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-07-15
    End date: 2002-07-15

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Angiogram

Gadolinium IN Unspecified Drug
    Dosage: 20cc injected
    Start date: 2002-07-15

Omniscan
    Indication: Angiogram

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Angiogram
    Start date: 2001-05-14

Multihance
    Indication: Angiogram

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Angioplasty
    Start date: 2004-06-21

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Indication: Imaging Procedure

Prohance
    Indication: Angiogram

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2000-05-26

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2004-11-06

Magnevist
    Indication: Angiogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 1999-07-10
    End date: 1999-07-10

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2002-07-18

Gadolinium IN Unspecified Drug
    Dosage: 30cc
    Start date: 2003-11-20

Other drugs received by patient: Flonase; Plavix; Metoprolol; Zocor; Coumadin; Singulair; Renagel; Sertraline Hydrochloride; Furosemide; Procrit; Allegra; Procrit; Iron [citric Acid,ferrous Sulfate]; Valsartan; Vitaplex; Actos; Glipizide; Ramipril



Possible Optimark side effects in 73 year old male

Reported by a lawyer from United States on 2011-11-08

Patient: 73 year old male

Reactions: Pain, Joint Contracture, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Emotional Distress, Anxiety, Anhedonia, Joint Range of Motion Decreased, Injury, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Multihance
    Indication: Angiogram

Prohance
    Indication: Angiogram

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2000-05-26

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: 20cc injected
    Start date: 2002-07-15

Gadolinium IN Unspecified Drug
    Dosage: 30cc
    Start date: 2003-11-20

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2002-07-18

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Angiogram

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Angioplasty
    Start date: 2004-06-21

Magnevist
    Indication: Angiogram

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Angiogram

Omniscan
    Dosage: 20cc
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-07-15
    End date: 2002-07-15

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 1999-07-10
    End date: 1999-07-10

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Angiogram
    Start date: 2001-05-14

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2004-11-06

Gadolinium IN Unspecified Drug
    Indication: Imaging Procedure

Other drugs received by patient: Procrit; Coumadin; Plavix; Actos; Zocor; Renagel; Glipizide; Ramipril; Procrit; Singulair; Allegra; Sertraline Hydrochloride; Flonase; Vitaplex; Iron [citric Acid,ferrous Sulfate]; Furosemide; Valsartan; Metoprolol



Possible Optimark side effects in 42 year old male

Reported by a lawyer from United States on 2011-10-20

Patient: 42 year old male

Reactions: Pain, Joint Contracture, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Emotional Distress, Anxiety, Musculoskeletal Stiffness, Fibrosis, Gait Disturbance, Asthenia, Scar, Mobility Decreased, Extremity Contracture

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist

Other drugs received by patient: Prograf; Glucagon; Cartia XT; Ranitidine; Antineoplastic Agents; Diclofenac Sodium ER; Vicodin; Mycophenolate Mofetil (Cellcept); Omega-3 Fatty Acids; Novolog; Lantus; Pancrelipase; Glipizide; Fexofenadine; Labetalol HCL; Prednisone; Paracetamol W / Tramadol Hydrochloride; Therems



Possible Optimark side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-10

Patient: 43 year old male, weighing 118.0 kg (259.6 pounds)

Reactions: Pain in Extremity, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Deformity, Skin Tightness, Emotional Distress, Anxiety, Skin Discolouration, Depression, Fibrosis, Mobility Decreased, Scar

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: 20 ml, once
    Start date: 2006-05-21
    End date: 2006-05-21

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-04-25
    End date: 2006-04-25

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Insulin [insulin]; Zemplar; Cardizem; Losartan Potassium; Albumin (Human); Aranesp; Phoslo; Catapres; Nephrocaps; Procardia XL; Procrit; Aldactone

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014